Alimera Sciences RPE
What is the RPE of Alimera Sciences?
The RPE of Alimera Sciences Inc. is $204.684k
What is the definition of RPE?
Revenue per employee (RPE) is revenue divided by the number of employees of an organization.
= net income / number of employees
RPE of companies in the Health Care sector on NASDAQ compared to Alimera Sciences
What does Alimera Sciences do?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Companies with rpe similar to Alimera Sciences
- Coveo Solutions has RPE of $204.448k
- Verint Systems has RPE of $204.498k
- Nacon S.A has RPE of €204.512k
- MJ Hudson plc has RPE of £204.526k
- ConvaTec Plc has RPE of $204.575k
- Shield Therapeutics Plc has RPE of £204.600k
- Alimera Sciences has RPE of $204.684k
- Société BIC SA has RPE of €204.760k
- Metals Exploration plc has RPE of $204.791k
- Edenred SA has RPE of €204.929k
- Coherent Corp has RPE of $204.958k
- Calibre Mining has RPE of $205.044k
- Credit Corp has RPE of AUD$205.326k